HLA-DR3 restricted environmental epitopes from the bacterium Clostridium tetani have T cell cross-reactivity to the SLE-related autoantigen SmD

HLA-DR3 (DR3) is one of the dominant HLA-DR alleles associated with systemic lupus erythematosus (SLE) susceptibility. Our previous studies showed multiple intramolecular DR3 restricted T cell epitopes in the Smith D (SmD) protein, from which we generated a non-homologous, bacterial epitope mimics l...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in immunology Vol. 13; p. 928374
Main Authors Zhao, Zhenhuan, Anderson, Ashley N., Kannapell, Carol C., Kwok, William W., Gaskin, Felicia, Fu, Shu Man
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 31.10.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:HLA-DR3 (DR3) is one of the dominant HLA-DR alleles associated with systemic lupus erythematosus (SLE) susceptibility. Our previous studies showed multiple intramolecular DR3 restricted T cell epitopes in the Smith D (SmD) protein, from which we generated a non-homologous, bacterial epitope mimics library. From this library we identified ABC 247-261 Mimic as one new DR3 restricted bacterial T cell epitope from the ABC transporter ATP-binding protein in Clostridium tetani . It activated and induced autoreactive SmD 66-80 -specific T cells and induced autoantibodies to lupus-related autoantigens in vivo . Compared to healthy donors, SLE patients have a greater percentage of cross-reactive T cells to ABC 247-261 Mimic and SmD 66-80 . In addition, we analyzed the ability of single DR3 restricted Tetanus toxoid (TT) T cell epitopes to induce autoimmune T cells. We found that the immunodominant TT epitope TT 826-845 stimulated SmD 66-80 reactive T cells but failed to induce persistent anti-SmD autoantibodies compared to the ABC 247-261 Mimic. Thus, exposure to the ABC 247-261 Mimic epitope may contribute to autoimmunity in susceptible DR3 individuals.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Edited by: Diego Francisco Catalán, University of Chile, Chile
Reviewed by: Ricardo Pujol Borrell, Universitat Autònoma de Barcelona, Spain; Katina Schinnerling, University of Chile, Chile
This article was submitted to Autoimmune and Autoinflammatory Disorders, a section of the journal Frontiers in Immunology
ISSN:1664-3224
1664-3224
DOI:10.3389/fimmu.2022.928374